Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Laurence Alexander
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 42on tracked calls
- Challenge rate
- 12%5 of 42 questions
- Companies
- 10questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 42 of 42 questions from 10 companies
ALBAlbemarle Corporation10 questions · 6 reporting periods · 2 of 10 challenging
Calendar 2026 Q2
can you give your perspective on the attractiveness or not of projects elsewhere in Chile?
Show response
Kent said Albemarle is prioritizing the Salar de Atacama DLE project first and will assess other Chilean and South American resources only after executing there.
Calendar 2026 Q1
can you talk a little bit about whether there's any advantages or disadvantages for you if the LFP producers need to switch to yellow phosphorus to reduce their sulfur consumption
Show response
Norris said sulfuric acid cost increases are a significant driver of the $70-90M supply chain headwind, affecting all hard rock conversion operators equally. Chinese LFP cathode producers have upstream capabilities to access phosphorus in various forms without quality impact.
what would you see as like the desirable range for your balance sheet? And what balance sheet metrics would you use as boundary conditions?
Show response
Sheorey emphasized conservative posture given the extreme volatility over the past 5 years. Kings Mountain is nowhere near a final investment decision. No specific target metrics shared.
Calendar 2025 Q4
How are you thinking about the development of solid state as a solution in the battery market? And the potential competitive threats from sodium-ion batteries?
Show response
Masters said solid state is positive for lithium (2x lithium content per battery) but not mass market yet. Sodium-ion needs more energy density to be cost competitive with LFP and is limited by volumetric density constraints. ALB models 10% sodium-ion in fixed storage growing to 15% by end of decade.
can you discuss whether there is any material difference in contract structures developing between stationary storage and automotive
Show response
Masters and Norris explained that fixed storage is largely carbonate/LFP in China on spot pricing, while hydroxide for automotive is more differentiated with detailed qualification processes and long-term contracts. Carbonate has a more harmonized spec, closer to a classic commodity.
Calendar 2025 Q3
Is your cost structure at the point where if prices do not improve next year, your cash flow -- you are free cash flow positive?
Show response
Masters declined to forecast 2026 but expressed confidence in the cost-out mentality built across the organization, especially in operations.
What do you see as kind of the appropriate return hurdles for you to engage in new projects
Show response
Masters said return hurdles haven't changed but current market pricing doesn't support them. Strategy is to compete through the trough and stay agile for the upturn.
Calendar 2025 Q2
can you maintain free cash flow positive if we're at $9 per kilo on average in 2026, 2027, 2028
Show response
Sheorey outlined multiple tailwinds for 2026+: full-year cost savings, further asset ramps, reduced tolling, Talison JV dividend normalization, and continued CapEx discipline.
Calendar 2024 Q4
how much of your capacity is under long-term contract compared to the EV market?
Show response
Masters clarified the 50% floor-based contracts plus additional longer-term agreements without floors, now categorized as spot.
For the $350 million of cash inflows, just to be clear, if -- would the net effect be that the EBITDA related to that would show up in 2026 or '27
Show response
Sheorey confirmed the prepayment was received upfront but EBITDA recognition will occur incrementally over 5 years of deliveries.
ECLEcolab7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
Are you mostly winning share in the early stage preclinical or are you also getting the equivalent share gains
Show response
Beck declined stage-level detail on competitive sensitivity grounds but confirmed investing ahead of growth, citing 10 points between the reported and underlying figures he described.
Calendar 2026 Q1
is your percentage value capture across your portfolio increasing? Or is it a matter of delivering more value
Show response
Beck said pricing approach has been perfected over 4-5 years. Haven't lost customers, margins went up, retention remains strong. Surcharges convert to structural pricing.
Calendar 2025 Q4
What type of M&A would you consider that would, you know, structurally push back the margin target a few years?
Show response
Beck firmly stated 20% OI margin by 2027 unchanged. M&A must be growth and margin accretive. Never do deals that destroy shareholder value. 100 deals completed in last 10 years with strong track record. Then 100-150bps annual expansion beyond 2027.
Calendar 2025 Q3
Can you talk a little bit about the gives and takes and what levers you have to pull if currency moves the other way next year?
Show response
Kirkland noted underlying OI growing double digits regardless of FX. Q3 FX in line with guidance. Year-over-year SG&A comp was headwind in Q3 but expects normalization in Q4. Commodity costs growing low to mid-single digits being overcome.
Calendar 2025 Q2
How do the IRRs and cash paybacks or payback period compare with the more traditional investments that Ecolab would do in the institutional and in the Nalco business
Show response
Beck couldn't quantify exact IRR comparison but noted growth engines at ~$3B growing double digits with margins closer to 30% than 20%, implying above-average returns. Cited data center cooling, water circularity for fabs, biopharma, and Ecolab Digital as key investment areas.
Calendar 2025 Q1
how a shift in The U.S. to aggressive deregulation would either create opportunities or headwinds for your institutional and pest businesses
Show response
Beck noted no visible impact from deregulation yet on any business. Remains hopeful it helps US industry including downstream business.
Calendar 2024 Q4
Could you give us a sense of your assumptions for 2025 around SG&A leverage, taxes, interest expense, and buybacks?
Show response
Kirkland outlined SG&A leverage 20-30bps (lower end), tax rate 20-21% vs 19.3% in 2024, normal buyback levels. Balance sheet at 1.7x net leverage.
IFFInternational Flavors & Fragrances6 questions · 6 reporting periods · 1 of 6 challenging
Calendar 2026 Q2
is the decision not to increase R&D or not to allocate any of the proceeds to R&D an indication that you're comfortable with your competitive moat?
Show response
Erik said IFF has raised R&D from about 7% to about 9% of sales over 2.5 years, will keep increasing spend as sales grow, and remains committed to competing hard in China as a critical market.
Calendar 2026 Q1
one of your goals for the segments was to recoup the share positions that they used to have with a flat to higher gross margin for each of the subunits. Can you give an update on that strategy
Show response
Erik provided comprehensive segment-by-segment update: Taste performing ahead of market with strong pipeline; H&B enzymes/cultures strong, health turning around H2 2026; Scent Fine Fragrance strong, Consumer Fragrance rebuilding, commodity ingredients to stop being headwind by 2027; Food Ingredients margins from 9% to projected 14%+ this year.
Calendar 2025 Q4
what are you assuming for destocking risk this year compared to the last couple of years?
Show response
Erik confirmed reasonable destocking risk embedded in guidance range. Noted 1-4% includes Food Ingredients which will grow modestly. H2 expected better as innovation kicks in with macro geopolitics unpredictable.
Calendar 2025 Q3
Can you give us some color on what your customers are telling you about inventory levels and their patience on reformulations?
Show response
DeVeau acknowledged North America customer inventories slightly elevated, embedded in forecast as potential deceleration risk. Globally inventories in good shape. Argued innovation will remain central to customer strategies. Erik added IFF is managing its own inventories while ensuring delivery reliability.
Calendar 2025 Q2
Can you give a bit more granularity about what's happening sequentially in end market trends in Taste and Scent, your confidence on the end markets into 2026
Show response
Erik detailed Taste slowdown in U.S./China/SE Asia but continued strength in LatAm, Europe, India, Middle East. Fine Fragrance double-digit growth continuing into H2 and 2026. Consumer Fragrance low single digit. Fragrance Ingredients negative H2, flattening 2026, growth returning 2027.
Calendar 2025 Q1
how you think about the inventory cycle and the bullwhip effect and how that might affect IFF
Show response
DeVeau argued inventory levels are not elevated given the recent significant destocking cycle, and that this cycle is different from past ones in both magnitude and duration.
SHWThe Sherwin-Williams Company5 questions · 5 reporting periods · 1 of 5 challenging
Calendar 2025 Q4
Could you give an update on what your net price tailwind is expected to be going into 2026
Show response
Ben noted Jan 1 pricing annualizes cleanly; Jim added low single-digit positive price mix across all three segments for full year 2026.
Calendar 2025 Q3
are you pulling forward some of the share gains that we would normally see in a recovery?
Show response
Heidi said SHW is not pulling forward share gains; expects structural competitive advantage when recovery comes, amplified by exclusive contracts.
Calendar 2025 Q2
could you give a bit more detail on what you are seeing in refinish? You mentioned kind of lapping the comps will help.
Show response
Heidi noted no underlying refinish industry improvement but SHW taking share via new accounts and collision core momentum; Al reiterated ~$80M annual savings phasing and 2% of sales CapEx target going forward.
Calendar 2025 Q1
Would you mind giving some detail around what you're seeing in terms of labor availability, maybe by channel, and what that -- is it getting easier to poach salespeople from competitors
Show response
Heidi said no significant labor concern; SHW's talent acquisition, Create Your Possible internal mobility program, and culture drive retention; talent is the enabler of all enterprise priorities.
Calendar 2024 Q4
What has to go right for you to hit the high end of the guidance and what might go wrong
Show response
Question asked by Karen Jung on behalf of Laurence Alexander. Al framed the guidance range as driven primarily by where Paint Stores Group volume lands, the fastest-growing and most profitable segment dictates where they land on EPS.
APDAir Products4 questions · 4 reporting periods · 1 of 4 challenging
Calendar 2026 Q2
could you give a quick update on what you're seeing on the merchant volumes by region?
Show response
Eduardo said Americas merchant volumes are still growing, Europe remains a difficult non-growing industrial market, and China is somewhat better but with overcapacity; APD's non-electronics merchant exposure in Asia is flattish.
Calendar 2025 Q4
If it comes in better than expected or compared to expectations a few years ago, do the benefits accrue to your on-site business?
Show response
Eduardo distinguished between energy cost AI savings (partially passed through in on-site contracts) and SG&A/engineering AI savings (retained internally). Power consumption reductions captured by APD since customer contracts guarantee maximum consumption levels.
Calendar 2025 Q3
what was your assumption around NEOM? Was it your predecessors' framework of realized prices will be roughly double the market price?
Show response
Eduardo confirmed NEOM has only minimal contribution assumed in the high single-digit growth guidance through FY2029. JV contribution included but product commercialization earnings not meaningfully forecasted yet.
Calendar 2024 Q3
can you walk through kind of the contractual differences that - the opportunities that you've been able to capture that you would never get again?
Show response
Seifi emphasized no other company will have commercial-scale green hydrogen by 2030 compliance deadlines, giving Air Products pricing power in contract negotiations.
PPGPPG Industries4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
do you expect based on what you have visibility on now to be running -- is that gap widening going into next year?
Show response
Lopez and Knavish both answered, guiding to continued but narrower outperformance and describing the auto innovation pipeline.
Calendar 2025 Q4
given it's a you're leveraging internal projects, do you have enough data to see what your paybacks are like on incremental investments?
Show response
Knavish confirmed early AI ROI indicators very favorable: millions already booking to bottom line from 50 optimized formulas, though not yet material to company. Pipeline suggests materiality is yet to come. Morales confirmed industrial share gains would be additive in a cyclical recovery, 'canary in the coal mine' business.
Calendar 2025 Q3
your content per plane over time should grow about 1% or 2% faster than inflation. Is that roughly right?
Show response
Knavish corrected, growing much more than 1-2%. Four components: sealants (biggest, with value-add frozen end cap packaging and 3D printing), transparencies (canopies/windshields with increasing content per new design), traditional coatings, and value-add services. Prefers calling it 'aerospace' not 'aerospace coatings' given breadth.
Calendar 2025 Q1
I think in the prepared remarks, you indicated your thought momentum would be accelerating in the -- over the next several quarters. And it sounds as if you were referring to the underlying end mar...
Show response
Knavish confirmed both end-market upticks and booked share gains driving momentum. Not a big player in wood. Heavy-duty remains down. General finishes and coil doing well. China and India growing across multiple segments.
Show 4 more companies
MMM3M Company3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
Can you give a high-level assessment of the margin profile in the new product mix relative to your core businesses?
Show response
Bill said new products start at lower volumes but lift overall margin over time through pricing on new features and design-to-cost.
Calendar 2026 Q1
can you just address what your customers are saying about potential supply chain bottlenecks
Show response
Brown acknowledged supply chain concerns are affecting pre-buy behavior and cited Strait of Hormuz risk, but provided limited specifics on bottleneck severity.
Calendar 2025 Q2
how do you think about the effect of your metering of investments on operating leverage if demand surprises
Show response
Anurag said incremental margins ~35% today with potential to go higher if volume picks up; $175M step-up investment this year, metering done in response to demand calibration.
CTVACorteva1 question · 1 reporting period · 0 of 1 challenging
Calendar 2025 Q4
Does this figure also account for the potential secondary effects such as increased dumping of generic product in non-tariff market like Brazil?
Show response
Robert confirmed the $80M tariff estimate encompasses all countries including Brazil. Chuck clarified almost all tariff impact is from Chinese CP actives entering the US, which is by far the biggest component.
DDDuPont1 question · 1 reporting period · 0 of 1 challenging
Calendar 2024 Q4
What specifically are you assuming for remodeling activity? And also, what's your assumption around FX?
Show response
Koch guided flat remodeling activity and quantified FX headwind at 1.5% in Q1 and 1% for full year.
LINLinde plc1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q1
are you seeing in any regions or significant delays in projects where you're seeing kind of the CapEx decisions at least get delayed
Show response
White confirmed no delays in existing backlog. New project interest varies by geography, electronics and space strong globally, traditional industrial more geographic-specific. Force majeure language well-tested; economic weakness is not force majeure.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| ALB Albemarle Corporation | 10 | 20%2 of 10 questions |
| ECL Ecolab | 7 | 0%none of 7 questions |
| IFF International Flavors & Fragrances | 6 | 17%1 of 6 questions |
| SHW The Sherwin-Williams Company | 5 | 20%1 of 5 questions |
| APD Air Products | 4 | 25%1 of 4 questions |
| PPG PPG Industries | 4 | 0%none of 4 questions |
| MMM 3M Company | 3 | 0%none of 3 questions |
| CTVA Corteva | 1 | —Rate withheld: fewer than 3 questions |
| DD DuPont | 1 | —Rate withheld: fewer than 3 questions |
| LIN Linde plc | 1 | —Rate withheld: fewer than 3 questions |
- ALBAlbemarle Corporation · 10 questions20%2 of 10 questions
- ECLEcolab · 7 questions0%none of 7 questions
- IFFInternational Flavors & Fragrances · 6 questions17%1 of 6 questions
- SHWThe Sherwin-Williams Company · 5 questions20%1 of 5 questions
- APDAir Products · 4 questions25%1 of 4 questions
- PPGPPG Industries · 4 questions0%none of 4 questions
- MMM3M Company · 3 questions0%none of 3 questions
- CTVACorteva · 1 question—rate withheld: under 3 questions
- DDDuPont · 1 question—rate withheld: under 3 questions
- LINLinde plc · 1 question—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 1 | 0%none of 1 question | 1 |
| 2024 Q4 | 5 | 0%none of 5 questions | 4 |
| 2025 Q1 | 4 | 0%none of 4 questions | 4 |
| 2025 Q2 | 5 | 20%1 of 5 questions | 5 |
| 2025 Q3 | 7 | 43%3 of 7 questions | 6 |
| 2025 Q4 | 8 | 0%none of 8 questions | 7 |
| 2026 Q1 | 6 | 0%none of 6 questions | 5 |
| 2026 Q2 | 6 | 17%1 of 6 questions | 6 |
- 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2024 Q45 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2025 Q14 questions · challenge rate 0% (none of 4 questions) · 4 companies
- 2025 Q25 questions · challenge rate 20% (1 of 5 questions) · 5 companies
- 2025 Q37 questions · challenge rate 43% (3 of 7 questions) · 6 companies
- 2025 Q48 questions · challenge rate 0% (none of 8 questions) · 7 companies
- 2026 Q16 questions · challenge rate 0% (none of 6 questions) · 5 companies
- 2026 Q26 questions · challenge rate 17% (1 of 6 questions) · 6 companies
Topics
Topics tagged on this analyst’s questions.
- Competitive Dynamics13
- Margin12
- Innovation & R&D10
- Demand9
- Capex Investment8
- Capital Allocation5
- Pricing5
- Macroeconomic4
- Supply Chain4
- Revenue Growth3
Show all 18 topics
- Cost Pressure2
- Guidance Reliability2
- Fx2
- Cloud & AI1
- Trade Tariffs1
- M&A1
- Regulation Policy1
- Labor Market1